Figure 2.
Combinatorial dose response to decitabine (5A2D) and romidepsin (Rom) in ccRCC and TNBC cell lines. (A) A498, (B) KIJ265T, (C) MDA-231, and (D) BT-20 cells were incubated with a dose of 0.1, 1, or 10μM decitabine for 48hrs. Romidepsin (0.5 to 7.5nM) was added in combination to the decitabine for a further 24hrs. Data is presented as proliferation curves with monotherapeutic controls included.